Bioneer Corporation

Bioneer Corporation

Share · KR7064550007 (XKOS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Bioneer Corporation
No Price
Closing Price XKOS 29.04.2026: 10.910,00 KRW
29.04.2026 06:30
Current Prices from Bioneer Corporation
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
064550.KQ
KRW
29.04.2026 06:30
10.910,00 KRW
10,00 KRW
+0,09 %
Share Float & Liquidity
Free Float 82,12 %
Shares Float 21,2 M
Shares Outstanding 25,81 M
Invested Funds

The following funds have invested in Bioneer Corporation:

Fund
iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist)
Vol. in million
221,18
Percentage (%)
0,22 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
49,31
Percentage (%)
0,02 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
249,61
Percentage (%)
0,02 %
Company Profile for Bioneer Corporation Share
Bioneer Corporation engages in the biotechnology research products, molecular diagnosis, drugs, and probiotics businesses in South Korea. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide functional analysis, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, electrophoresis, spectrophotometer, and microbial culture. It also provides molecular diagnosis, including MDx technologies, human diagnostics kits, MDx extraction kits, and instruments; and products for animal diseases and nano-bio products. The company was founded in 1992 and is headquartered in Daejeon, South Korea.

Company Data

Name Bioneer Corporation
Company Bioneer Corporation
Website https://www.bioneer.co.kr
Primary Exchange XKOS KOSDAQ
ISIN KR7064550007
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Han-Oh Park
Market Capitalization 281 Mrd.
Country South Korea
Currency KRW
Employees 0,6 T
Address 8-11, Munpyeongseo-ro, Daejeon
IPO Date 2005-12-29
Dividends from 'Bioneer Corporation'
Ex-Date Dividend per Share
15.03.2022 0,29 KRW

Stock Splits

Date Split
15.05.2017 43:40

Ticker Symbols

Name Symbol
KOSDAQ 064550.KQ
More Shares
Investors who hold Bioneer Corporation also have the following shares in their portfolio:
AMPOL LTD
AMPOL LTD Share
CH.G.W.I.HLD.III 17/27MTN
CH.G.W.I.HLD.III 17/27MTN Bond